This first pan-cancer analysis of VDR indicates that VDR may serve as a prognostic biomarker and VDR is positively associated with immune infiltration as well as stromal or immune components in the tumor microenvironment in multiple human cancers. This evidence concerns the gene VDR and neoplasm.